Proton magnetic resonance spectroscopy: Clinical applications in patients with brain lesions

Sao Paulo Medical Journal

Volumn 121, Issue 6, 2003, Pages 254-259

  Ramin, Sérgio Luis ^a,b   Tohnola, Walder Antonio ^a   Spotti, Antonio Ronaldo ^a  

^a FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^b NONE   (Brazil)

Author keywords

Brain; Magnetic; Proton; Resonance; Spectroscopy

Indexed keywords

AMINO ACID; BIOCHEMICAL MARKER; CHOLINE; CREATININE; INOSITOL; LIPID; N ACETYLASPARTIC ACID;

ALZHEIMER DISEASE; ARTICLE; BRAIN ABSCESS; BRAIN INJURY; BRAIN NECROSIS; BRAIN TISSUE; BRAIN TUMOR; CLINICAL PRACTICE; CONCENTRATION (PARAMETERS); HUMAN; IN VIVO STUDY; METABOLITE; NERVE CELL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0348149051     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-31802003000600008     Document Type: Article

References (75)

1. Lenkinski RE, Schnall MD. MR Spectroscopy and the biochemical basis of neurological. In: Atlas SW, editor. Magnetic resonance imaging of the brain and spine. Philadelphia: Lippincott-Raven; 1996. p.1619-53.
2. Alger JR, Frank JA, Bizzi A, et al. Metabolism of human gliomass: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 1990;177(3):633-41.
3. Luyten PR, Marien AJ, Heindel W, et al. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 1990;176(3):791-9.
4. Norfray J, Byrd SE, Schwalm CA. Magnetic resonance spectroscopy. In: McLone DG, ed. Pediatric neurosurgery. Philadelphia: WB Saunders; 2001. p.1189-203.
5. Kuzniecky R. Magnetic resonance spectroscopy in focal epilepsy: 31P and 1H spectroscopy. Rev Neural 1999;155(6-7):495-8.
6. Ross B, Mechaelis T. MR spectroscopy of the brain: neurospectroscopy. In: Hesselink JR, Zlatkin MB, Edelman RR, editors. Clinical magnetic resonance imaging. Philadelphia: WB Saunders; 1996. p.928-81.
7. van der Knaap MS, van der Grond J, van Rijen PC, Faber JA, Valk J, Willense K. Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 1990;176(2):509-15.
8. Peeling J, Sutherland G, Marat K, Tomchuk E, Bock E. 1H and 13C nuclear magnetic resonance studies of plasma from patients with primary intracranial neoplasms. J Neurosurg 1988;68(6):931-7.
9. 13C NMR spectroscopy in vivo. In: Weekend Educational Courses: MR spectroscopy. Honolulu: International Society for Magnetic Resonance in Medicine, 2002. p.88-95.
10. Weiner MW, Hetherington HP. The power of the proton. Radiology 1989;172(2):318-20.
11. Frahm J, Bruhn H, Gyngell ML, et al. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial application to human brain in vivo. Magn Reson Med 1989;9(1):79-83.
12. Frahm J, Bruhn H, Gyngell ML, et al. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med 1989;11(1):47-63.
13. Kwock L. Localized MR spectroscopy: basic principles. Neuroimaging Clin N Am 1998;8(4):713-31.
14. Butzen J, Prost R, Chetty V, Donahue K, Nepple R, Bowen W, et al. Discrimination between neoplastic and brain lesions by use of proton MR spectroscopy: the limits of accuracy with a logistic model. AJNR Am J Neuroradiol 2000;21(7):1213-9.
15. Wilken B, Dechent P, Herms J, et al. Quantitative proton magnetic resonance spectroscopy of focal brain lesions. Pediatr Neurol 2000;23(1):22-31.
16. Adamson AJ, Rand SD, Prost RW, et al. Focal brain lesions: effect of single-voxel proton MR spectroscopic findings on treatment decisions. Radiology 1998;209(1):73-8.
17. Simone IL, Federico F, Tortorella C, et al. Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. J Neural Neurosurg Psychiatry 1998;64(4):516-23.
18. Poptani H, Kaartinen J, Gupta RK, et al. Diagnostic assessment of brain tumours and non-neoplastic brain disorders in vivo using proton nuclear magnetic resonance spectroscopy and artificial neural networks. J Cancer Res Clin Oncol 1999;125(6):343-9.
19. Kaibara T, Tyson RL, Sutherland GR. Human cerebral neoplasms studied using MR spectroscopy: a review. Biochem Cell Biol 1998;76(2-3):477-86.
20. Cecil KM, Lenkinski RE. Proton MR spectroscopy in inflammatory and infectious brain disorders. Neuroimaging Clin N Am 1998;8(4):863-80.
21. Chang L, Miller BL, McBride D, et al. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995;197(2):525-31.
22. Chinn RJ, Wilkinson ID, Hall-Craggs MA, et al. Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy. Radiology 1995;197(3):649-54.
23. Chang L, Ernst T. Proton MRS to assess HIV-related brain diseases. In: Weekend Educational Courses: MR spectroscopy. Honolulu: International Society for Magnetic Resonance in Medicine; 2002. p.48-55.
24. Shonk TK, Moats RA, Gifford P, et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology 1995;195(1):65-72.
25. Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17(1):1-15.
26. Ross BD, Bluml S, Cowan R, et al. In vivo MR spectroscopy of human dementia. Neuroimaging Clin N Am 1998;8(4):809-22.
27. Cwik VS, Hanstock CC, Allen PS, et al. Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy. Neurology 1998;50(1):72-7.
28. Bizzi A, Movsas B, Tedeschi G, et al. Response of non-Hodgkin lymphoma to radiation therapy:early and long-term assessment with H-1 MR spectroscopic imaging. Radiology 1995;194(1):271-6.
29. Davidson A, Tait DM, Payne GS, et al. Magnetic resonance spectroscopy in the evaluation of neurotoxicity following cranial irradiation for childhood cancer. Br J Radiol 2000;73(868):421-4.
30. Yoshino E, Ohmori Y, Imahori Y, et al. Irradiation effects on the metabolism of metastatic brain tumors: analysis by positron emission tomography and 1H-magnetic resonance spectroscopy. Stereotact Funct Neurosurg 1996;66(Suppl 1):240-59.
31. Bruhn H, Frahm J, Merboldt KD, et al. Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic spectroscopy in vivo. Ann Neurol 1992;32(2):140-50.
32. De Stefano N, Caramanos Z, Preul MC, et al. In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging. Ann Neurol 1998;44(2):273-8.
33. Rovira A, Pericot I, Alonso J, Rio J, Grive E, Montalban X. Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report. AJNR Am J Neuroradiol 2002;23(6):989-94.
34. Bonavita S, Di Salle F, Tedeschi G. Proton MRS in neurological disorders. Eur J Radiol 1999;30(2):125-31.
35. Ricci PE Jr. Proton MR spectroscopy in ischemic stroke and other vascular disorders. Neuroimaging Clin N Am 1998;8(4):881-900.
36. Malisza LK, Kozlowski P, Peeling J. A review of in vivo 1H magnetic resonance spectroscopy of cerebral ischemia in rats. Biochem Cell Biol 1998;76(2-3):487-96.
37. Wang Z, Zimmerman RA, Sauter R, Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children. AJR Am J Roentgenol 1996;167(1):1384-91.
38. Friedman SD, Brooks WM, Jung RE, et al. Quantitative proton MRS predicts outcome after traumatic brain injury. Neurology 1999;52(7):1384-91.
39. Schuhmann MU, Stiller D, Thomas S, Brinker T, Samii M. 1H-MR spectroscopic monitoring of posttraumatic metabolism following controlled cortical impact injury: pilot study. Acta Neurochir Suppl 2000;76:3-7.
40. Sinson G, Bagley LJ, Cecil KM, et al. Magnetization transfer imaging and proton MR spectroscopy in the evaluation of axonal injury: correlation with clinical outcome after traumatic brain injury. AJNR J Neuroradiol 2001;22(1):143-51.
41. Garnett MR, Blamire AM, Rajagopalan B, Styles P, cadoux-Hudson TA. Evidence for cellular damage in normal-appearing white matter correlates with injury severity in patients following traumatic brain injury: a magnetic resonance spectroscopy study. Brain 2001;123(Pt 7):1403-9.
42. Gupta RK, Vatsal DK, Husain N, et al. Differentiation of tuberculous from pyogenic brain abscesses with in vivo proton MR spectroscopy and magnetization transfer MR imaging. AJNR Am J Neuroradiol 2001;22(8):1503-9.
43. Kuzniecky R, Hetherington H, Pan J, et al. Proton spectroscopic imaging at 4.1 tesla in patients with malformations of cortical development and epilepsy. Neurology 1997;48(4):1018-24.
44. Cendes F, Caramanos Z, Anderman F, Debeau F, Arnold DL, Proton magnetic resonance spectroscopic imaging magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: a series of 100 patients. Ann Neurol 1997; 42(5):737-46.
45. Mendes-Ribeiro JA, Soares R, Simões-Ribeiro G, Guimarães ML. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control? J Neurol Neurosurg Psychiatry 1998; 65(4):518-22.
46. Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 192;182(1):19-27.
47. Ross BD, Jacobson S, Villamil F, et al. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994;193(2):457-63.
48. Sutton LN, Wang Z, Gusnard D, et al. Proton magnetic resonance: spectroscopy of pediatric brain tumors. Neurosurgery 1992;31(2):195-202.
49. Taylor JS, Ogg RJ, Langston JW. Proton spectroscopy of pediatric brain tumors. Neuroimaging Clin N Am 1998;8(4):753-79.
50. Hunter JV, Wang ZJ. MR spectroscopy in pediatric neuroradiology. Magn Reson Imaging Clin Am 2001;9(1):165-89.
51. Westbrook C, Kaut C. Ressonância magneética prática. Rio de Janeiro: Guanabara Koogan; 2000.
52. Barker PB. Fundamentals of clinical MRS. In:. Weekend Educational Courses: MR spectroscopy. Honolulu: International Society for Magnetic Resonance in Medicine; 2002. p.1-9.
53. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84(3):449-58.
54. Maudsley AA. Spectroscopy imaging In: Weekend Educational Courses: MR spectroscopy. Honolulu: International Society for Magnetic Resonance in Medicine; 2002. p.7-23.
55. Dowling C, Bollen AW, Noworolski SM, et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimen. AJNR Am J Neuroradiol 2001;22(4):604-12.
56. Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical revelance. Radiology 1992;185(3):675-86.
57. Moonen CT, von Kienlin M, van Zijl PC, et al. Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy. Biomed 1989;2(5-6):201-8.
58. Hwang JH, Egnaczyk GF, Ballard E, et al. Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. AJNR Am Neuroradiol 1998;19(3):535-40.
59. Frahm J, Bruhn H, Hänicke W, et al. Localized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences. J Comput Assist Tomogr 1991;15(6):915-22.
60. Norfray JF, Tomita T, Byrd SE, et al. Clinical impact of MR spectroscopy when MR imaging is indetermine for pediatric brain tumors. AJR Am J Roentgenol 1999;173(1):119-25.
61. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987;508:333-48.
62. Alger JR. Magnetic resonance spectroscopy and neuro-oncology. In: Weekend Educational Course: MR Espectroscopia de próton. Honolulu: International Society for Magnetic Resonance in Medicine; 2002. p.39-43.
63. Brandão LA, Domingues RC. Espectroscopia de próton do encéfalo: princípiose e aplicações. Rio de Janeiro: Revinter; 2002.
64. Le Bas JF, Estève F, Grand S, et al. Spectroscopie RMN et pathologie cérébrale. Applications cliniques. [NMR spectroscopy and brain disease: clinical application]. J Neuroradiol 1998;25(1):55-69.
65. Grand S, Passaro G, Ziegler A, et al. Necrotic versus brain abscess: importance of amino acids detected at 1H MR spectroscopy - initial results. Radiology 1999;213(3):785-93.
66. Byrd SE, Tomita T, Palka PS, et al. Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors, Part II: Clinical analysis. J Natl Med Assoc 1996;88(11):717-23.
67. Kinoshita Y, Kajiwara H, Yokota A, Koga Y. Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. Neurosurgery 1994;35(4):606-13; discussion 613-4.
68. Kim DG, Choe WJ, Chang KH, et al. In vivo proton magnetic resonance spectroscopy of central neurocytomas. Neurosurgery 2000;46(2):329-33; discussion 333-4.
69. Norfray JF, Darling C, Bryd S, et al. Short TE proton MRS and neurofibromatosis type 1 intracranial lession. J Comput Assist Tomogr 1999;23(6):994-1003.
70. Auer DP, Gössl C, Schirmer T, Czisch M. Improved analysis of 1H-MR spectra in the presence of mobile lipids. Magn Reson Med 2001;46(3):615-8.
71. Hakumäki JM, Kauppinen RA, 1H NMR visible lipids in the life and death of cell. Trends Biochem Sci 2000;25(8):357-62.
72. Castillo M, Smith JK, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol 2000;21(9):1645-9.
73. Kimura T, Sako K, Gotoh T, Tanaka K, Tanaka T. In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement. NMR Biomed 2001;14(6):339-49.
74. Kadota O, Kohno K, Ohue S, Kumon Y, Sakaki S, Kikuchi K, et al. Discrimination of brain abscess and cystic tumor by in vivo proton magnetic resonance spectroscopy. Neurol Med Chir 2001;41(3):121-6.
75. Schlemmer HP, Bachert P, Herfarth KK, Zuna I, Debus J, van Kaick G. Proton MR spectroscopic evaluation of suspicious brain lesion after stereotactic radiotherapy. AJNR Am J Neuroradiol 2001;22(7):1316-24.